DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA

Abstract. Specific autoantibodies against acetylated, maleylated and malonic dialdehyde-(MDA)-modified lipoproteins are detectable in human plasma. Immunization of rabbits with autologous, correspondingly modified low-density lipoproteins (LDLs) did induce autoantibodies against acetylated, maleylat...

Full description

Saved in:
Bibliographic Details
Main Authors: P. V. Pigarevsky, O. Yu. Archipova, A. D. Denisenko
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/537
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849401394673483776
author P. V. Pigarevsky
O. Yu. Archipova
A. D. Denisenko
author_facet P. V. Pigarevsky
O. Yu. Archipova
A. D. Denisenko
author_sort P. V. Pigarevsky
collection DOAJ
description Abstract. Specific autoantibodies against acetylated, maleylated and malonic dialdehyde-(MDA)-modified lipoproteins are detectable in human plasma. Immunization of rabbits with autologous, correspondingly modified low-density lipoproteins (LDLs) did induce autoantibodies against acetylated, maleylated and MDA-modified lipoproteins. In atherosclerotic lesions from hyman aorta, the epitopes have been detected that were recognized by the antibodies to acetylated, maleylated, and MDA-modified LDLs. Such antigens were detected at all atherogenesis stages, beginning with the earliest lesions (lipid spots), and their deposition pattern was quite variable.Rabbit and human autoantibodies against acetylated, maleylated and MDA-modified lipoproteins recognized antigens in human atherosclerotic aorta. Modified proteins were localized both intra- and extracellular in tectum, superficial and deep layers of the atherosclerotic lesions. The most typical mode of depositions for all modified proteins si represented by extracellular deposits in the cap of lipid streaks and fibrous plaques, especially in transitional “shoulder” area.The intimal deposits of modified proteins shared similar features with distribution of apo-B-containing lipoproteins, like as of lipids detectable by Oil Red staining. The areas where modified proteins and apo-B-containing lipoproteins were revealed did often coincide with foci of IgG deposits. Modified proteins were not detectable in the non-affected segments of aortic intima.
format Article
id doaj-art-8457e47fce0645afa5106cdf27aa3bef
institution Kabale University
issn 1563-0625
2313-741X
language Russian
publishDate 2014-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj-art-8457e47fce0645afa5106cdf27aa3bef2025-08-20T03:37:46ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-0185-663764410.15789/1563-0625-2006-5-6-637-644534DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTAP. V. Pigarevsky0O. Yu. Archipova1A. D. Denisenko2ГУ НИИ Экспериментальной Медицины РАМН, г. Санкт-ПетербургГУ НИИ Экспериментальной Медицины РАМН, г. Санкт-ПетербургГУ НИИ Экспериментальной Медицины РАМН, г. Санкт-ПетербургAbstract. Specific autoantibodies against acetylated, maleylated and malonic dialdehyde-(MDA)-modified lipoproteins are detectable in human plasma. Immunization of rabbits with autologous, correspondingly modified low-density lipoproteins (LDLs) did induce autoantibodies against acetylated, maleylated and MDA-modified lipoproteins. In atherosclerotic lesions from hyman aorta, the epitopes have been detected that were recognized by the antibodies to acetylated, maleylated, and MDA-modified LDLs. Such antigens were detected at all atherogenesis stages, beginning with the earliest lesions (lipid spots), and their deposition pattern was quite variable.Rabbit and human autoantibodies against acetylated, maleylated and MDA-modified lipoproteins recognized antigens in human atherosclerotic aorta. Modified proteins were localized both intra- and extracellular in tectum, superficial and deep layers of the atherosclerotic lesions. The most typical mode of depositions for all modified proteins si represented by extracellular deposits in the cap of lipid streaks and fibrous plaques, especially in transitional “shoulder” area.The intimal deposits of modified proteins shared similar features with distribution of apo-B-containing lipoproteins, like as of lipids detectable by Oil Red staining. The areas where modified proteins and apo-B-containing lipoproteins were revealed did often coincide with foci of IgG deposits. Modified proteins were not detectable in the non-affected segments of aortic intima.https://www.mimmun.ru/mimmun/article/view/537autoantibodiesmodified lipoproteinsvascular wallimmunohistochemistry
spellingShingle P. V. Pigarevsky
O. Yu. Archipova
A. D. Denisenko
DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
Медицинская иммунология
autoantibodies
modified lipoproteins
vascular wall
immunohistochemistry
title DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
title_full DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
title_fullStr DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
title_full_unstemmed DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
title_short DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
title_sort detection of modified lipoproteins in atherosclerotic lesions of human aorta
topic autoantibodies
modified lipoproteins
vascular wall
immunohistochemistry
url https://www.mimmun.ru/mimmun/article/view/537
work_keys_str_mv AT pvpigarevsky detectionofmodifiedlipoproteinsinatheroscleroticlesionsofhumanaorta
AT oyuarchipova detectionofmodifiedlipoproteinsinatheroscleroticlesionsofhumanaorta
AT addenisenko detectionofmodifiedlipoproteinsinatheroscleroticlesionsofhumanaorta